Physician profile
Marcus Harris
NPI 1053847541
$8,969.42
in general payments reported to CMS, 2019-2025
30 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,171 · 2023: $3,951 · 2024: $1,607 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,712 · Travel and Lodging: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,711.91 |
| Travel and Lodging | $1,086.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,369.68 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $2,104.17 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,445.62 | 2022-2025 | General - Pain Management, General - Therapies, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $645.02 | 2022-2025 | Xtampza, Belbuca |
| Vertos Medical, INC. | $527.43 | 2023-2024 | Mild Device Kit |
| Abbott Laboratories | $522.72 | 2022-2025 | Eterna, Proclaim, Epic |
| Nevro Corp. | $189.05 | 2022-2024 | Senza |
| Nalu Medical, INC. | $146.77 | 2023-2024 | Nalu Neurostimulation System |
| Abbvie INC. | $113.67 | 2023-2025 | |
| Amgen INC. | $106.92 | 2024-2025 | Evenity, Prolia, Prolia |
| Lundbeck LLC | $103.08 | 2023-2024 | Vyepti |
| Globus Medical, INC. | $101.65 | 2025 | Senza, Vyrsa V1 |
| Biotronik Nro, INC. | $77.09 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.51 | 2023 | Relistor |
| Tersera Therapeutics LLC | $56.98 | 2023 | Prialt |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $51.53 | 2022 | |
| Spinal Simplicity, LLC | $44.58 | 2023-2025 | Ha Minuteman G3-R |
| Pacira Pharmaceuticals Incorporated | $44.38 | 2023-2024 | Zilretta, Iovera, Exparel |
| Intra-Sana Laboratories | $37.23 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Painteq LLC | $28.84 | 2024 | Painteq |
| Azurity Pharmaceuticals, INC. | $24.25 | 2024 | |
| Scilex Pharmaceuticals INC. | $24.18 | 2022 | |
| Si-Bone, INC. | $23.37 | 2023 | |
| Pfizer INC. | $17.80 | 2025 | |
| Radius Health, INC. | $17.19 | 2025 | |
| Lilly USA, LLC | $15.65 | 2023 | Reyvow, Emgality |
| Averitas Pharma INC. | $14.98 | 2023 | Qutenza |
| Impel Pharmaceuticals INC. | $14.66 | 2023 | Trudhesa |
| Stryker Corporation | $13.90 | 2024 | Mild Device Kit |
| Convatec INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.